Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXOZYMES INC. Director's Dealing 2025

Jun 20, 2025

34055_dirs_2025-06-20_7245253e-726a-4333-810f-2e284455b56e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXOZYMES INC. (EXOZ)
CIK: 0002010788
Period of Report: 2025-06-17

Reporting Person: Heltzen Michael (Chief Executive Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-17 Stock Options for Common Stock $12.40 A 235817 Acquired 2032-06-29 Common Stock (235817) Direct

Footnotes

F1: The Options will vest over a four (4) year period, in equal quarterly installments at the end of each quarter of the calendar year, and the Options will commence vesting on July 1, 2025.The option expires June 29, 2032.